Form 4: Hanover Insurance Group CEO Sells Shares
Insider Transaction (Form 4)
John C Roche, President and CEO and a Director of Hanover Insurance Group, Inc., sold 14,422 shares of common stock on November 11, 2026.
Summary
- Option exercise/conversion: acquired 48,052 Common Stock at $104.11 ($5,002,694) on November 11, 2026; holds 189,305 after (Direct).
- Option exercise/conversion: acquired 36,539 Common Stock at $117.22 ($4,283,102) on November 11, 2026; holds 225,844 after (Direct).
- Tax/exercise-price withholding: disposed of 60,198 Common Stock at $248.53 ($14,961,009) on November 11, 2026; holds 165,646 after (Direct).
- Open-market sale: disposed of 1,100 Common Stock at $247.93 ($272,726) on November 12, 2026; holds 164,546 after (Direct).
- Open-market sale: disposed of 10,393 Common Stock at $249.37 ($2,591,674) on November 12, 2026; holds 154,153 after (Direct).
- Open-market sale: disposed of 2,929 Common Stock at $250.00 ($732,242) on November 12, 2026; holds 151,224 after (Direct).
- Option exercise/conversion: disposed of 48,052 Common Stock Option (right to buy) on November 11, 2026 (Direct).
- Option exercise/conversion: disposed of 36,539 Common Stock Option (right to buy) on November 11, 2026 (Direct).
Sentiment
Score: 3
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $3,596,642 of stock on the open market.
Insider Transactions
John C Roche — Director, Officer (President and CEO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-11-11 | Option exercise/conversion | Common Stock | 48,052 | $104 | $5.0M | 189,305.034 |
| 2026-11-11 | Option exercise/conversion | Common Stock | 36,539 | $117 | $4.3M | 225,844.034 |
| 2026-11-11 | Tax/exercise-price withholding | Common Stock | 60,198 | $249 | $15.0M | 165,646.034 |
| 2026-11-12 | Open-market sale | Common Stock | 1,100 | $248 | $272.7K | 164,546.034 |
| 2026-11-12 | Open-market sale | Common Stock | 10,393 | $249 | $2.6M | 154,153.034 |
| 2026-11-12 | Open-market sale | Common Stock | 2,929 | $250 | $732.2K | 151,224.034 |
| 2026-11-11 | Option exercise/conversion | Common Stock Option (right to buy) | 48,052 | — | — | 0 |
| 2026-11-11 | Option exercise/conversion | Common Stock Option (right to buy) | 36,539 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-11-11 | Option exercise/conversion (48,052 shares) |
| 2026-11-11 | Option exercise/conversion (36,539 shares) |
| 2026-11-11 | Tax/exercise-price withholding (60,198 shares) |
| 2026-11-12 | Open-market sale (1,100 shares) |
| 2026-11-12 | Open-market sale (10,393 shares) |
| 2026-11-12 | Open-market sale (2,929 shares) |
| 2026-11-11 | Option exercise/conversion (48,052 shares) |
| 2026-11-11 | Option exercise/conversion (36,539 shares) |
Keywords
insider transaction, Form 4, THG, HANOVER INSURANCE GROUP, INC., bearish, John C Roche
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.